The parameters of immune inflammation and haemostasis in patients with systemic lupus erythematosus (SLE) with antiphospholipid syndrome (APS) and without APS

被引：0

作者：

Arshinov, A., V ^{[1
]}

Emanuylov, V., I ^{[1
]}

Zubova, N., V ^{[1
]}

机构：

[1] Yaroslavl State Med Acad, Rheumatol, Yaroslavl, Russia

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PP-MO-260

引用

页码：406 / 406

页数：1

共 50 条

[41] The antiphospholipid syndrome in patients with systemic lupus erythematosus [J].

Pons-Estel, Guillermo J. ;

Andreoli, Laura ;

Scanzi, Francesco ;

Cervera, Ricard ;

Tincani, Angela .

JOURNAL OF AUTOIMMUNITY, 2017, 76 :10-20

[42] Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE) [J].

Miranda, Juan M. ;

Jara, Luis J. ;

Calleja, Concepcion ;

Saavedra, Miguel A. ;

Bustamante, Reyna M. ;

Angeles, Ulises .

REUMATOLOGIA CLINICA, 2009, 5 (05) :209-213

[43] Diagnosis and treatment of secondary antiphospholipid syndrome in systemic lupus erythematosus (SLE) [J].

Komarov, VT .

TERAPEVTICHESKII ARKHIV, 1998, 70 (08) :65-66

[44] Galectin-9 as a surrogate biomarker for IFNα in systemic lupus erythematosus with and without APS [J].

Sjowall, Christopher ;

Basu, Alolika ;

Eloranta, Maija-Leena ;

Gullstrand, Birgitta ;

Ronnblom, Lars ;

Bengtsson, Anders A. ;

Wettero, Jonas ;

Enocsson, Helena .

LUPUS, 2019, 28 :31-32

[45] Antiphospholipid antibodies and the antiphospholipid syndrome in patients with systemic lupus erythematosus [J].

Taouli, K. M. ;

Sari, R. ;

Kendouci, E. H. ;

Stambouli, O. B. ;

Schved, J. F. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 :419-419

[46] Studies of microparticles in patients with the antiphospholipid syndrome (APS) [J].

Vikerfors, A. ;

Mobarrez, F. ;

Bremme, K. ;

Holmstrom, M. ;

Agren, A. ;

Eelde, A. ;

Bruzelius, M. ;

Antovic, A. ;

Wallen, H. ;

Svenungsson, E. .

LUPUS, 2012, 21 (07) :802-805

[47] Pilot study of a usb drive personal health record (PHR) for systemic lupus erythematosus (SLE) & antiphospholipid antibody syndrome (APS) patient empowerment & care quality improvement [J].

McCarty, G. A. ;

Cason, T. E. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) :142-142

[48] SEVERE SYSTEMIC HYPERTENSION DUE TO RENAL-ARTERY LESION IN SYSTEMIC LUPUS WITH ANTIPHOSPHOLIPID SYNDROME (APS) [J].

CACOUB, P ;

PIETTE, JC ;

WECHSLER, B ;

PAPO, T ;

PIETTE, AM ;

CHERIN, P ;

LEBRUN, P ;

BLETRY, O ;

BEAUFILS, H ;

GODEAU, P .

ARTHRITIS AND RHEUMATISM, 1993, 36 (09) :S186-S186

[49] Studies of microparticles in patients with antiphospholipid syndrome (APS) [J].

Vikerfors, A. ;

Mobarrez, F. ;

Bremme, K. ;

Holmstrom, M. ;

Agren, A. ;

Eelde, A. ;

Bruzelius, M. ;

Antovic, A. ;

Wallen, H. ;

Svenungsson, E. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 :626-626

[50] Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone [J].

Moss, KE ;

Isenberg, DA .

RHEUMATOLOGY, 2001, 40 (08) :863-867

← 1 2 3 4 5 →